BrainTale is an innovative company opening a new era in medicine. We aim at providing physicians with clinically validated diagnostic, monitoring and prognostic solutions for the management of brain injured patients through sensitive and reliable measurements of white-matter microstructure alterations. Building on more than 15 years of clinical development, BrainTale’s products are developed collaboratively to address medical need and fulfil expectations of healthcare professionals and patients alike.

Our team is composed of experienced, passionate and committed professionals. We are eager to deliver and to make the difference. In daily contact with patients, our approach is concrete, humanistic and realistic at the service of health.